Talaris Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Talaris Therapeutics generated cash of -$60,857,000, which is less than the previous year. Cash used in financing activities reached the amount of $242 last year. Net change in cash is therefore -$4,944,000.
Cash Flow
| 2019 | -17.66M | -562K | 36.20M |
|---|---|---|---|
| 2020 | -19.21M | -133.3M | 131.12M |
| 2021 | -39.98M | -96.38M | 137.4K |
| 2022 | -60.85M | 55.67M | 242 |
TALS Cash Flow Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Cash at beginning of period | 18.61M | 17.58M | 38.97M | 20.99M |
Operating activities | ||||
Net income | -73.89M | -47.83M | -22.70M | -18.15M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 2.16M | 623K | 447K | 379K |
Stock-based compensation expense | 11.15M | 3.77M | 1.02M | 229K |
| Deferred income tax benefit | 11.15M | 3.77M | 1.02M | 229K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | 1.66M | 1.32M | 100K | 321K |
Cash generated by operating activities | -60.85M | -39.98M | -19.21M | -17.66M |
Investing activities | ||||
Purchases Of Investments | -191.57M | -275.87M | -158.23M | 0 |
Investments In Property Plant And Equipment | -3.04M | -2.43M | -1.28M | -562K |
Acquisitions Net | -58.71K | 93.95K | 0 | 0 |
Cash generated by investing activities | 55.67M | -96.38M | -133.3M | -562K |
Financing activities | ||||
Common Stock Issued | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 |
Cash used in financing activities | 242 | 137.4K | 131.12M | 36.20M |
Net Change In Cash | -4.94M | 1.02M | -21.38M | 17.98M |
Cash at end of period | 13.67M | 18.61M | 17.58M | 38.97M |
| Data source | Data source |